Gyanendra Gupta
Gagan Devi
Abstract
The endocrine system plays a pivotal role in orchestrating and sustaining diverse
physiological functions by manufacturing and releasing hormones, which function as
vital chemical messengers within the body. Among the prominent endocrine glands,
the thyroid gland holds a central position. Situated in the lower part of the neck, this
gland adopts a butterfly-shaped structure. Its significance lies in the synthesis of three
key hormones: thyroxine (T4), tri-iodothyronine (T3), and calcitonin.The thyroid
hormones, T3 and T4, collectively referred to as thyroid hormone, are intricately
crafted within the follicles of the thyroid gland. These hormones wield substantial
influence over metabolic processes, playing a crucial role in regulating energy
expenditure and the overall metabolic rate of the body. Their synthesis is a finely
tuned process that contributes significantly to the maintenance of homeostasis.In
2
addition to T3 and T4, the thyroid gland houses parafollicular cells, also known as C
cells, interspersed between its follicles. These specialized cells take on the
responsibility of producing calcitonin, a hormone with a distinctive role in the body’s
calcium homeostasis. Calcitonin functions by modulating calcium levels, ensuring
that they remain within the normal range. By counteracting the actions of other
hormones involved in calcium regulation, calcitonin contributes to the overall
stability and health of the skeletal system.
his intricate interplay of hormones originating from the thyroid gland underscores its
multifaceted role in maintaining physiological equilibrium. From influencing
metabolic activity to actively participating in calcium regulation, the thyroid gland
serves as a linchpin in the delicate balance that defines optimal bodily function.
Understanding the complexities of its hormone production provides profound insights
into the broader landscape of endocrine control and its impact on overall well-being
Keywords: Endocrine system,Hormones,Thyroxine,Tri iodo thyronine and Calcitonin.
References
1.Guyton & Hall et al 12 th edition –Text Book Of Medical Physiology
2.Harrison‘s principles of INTERNAL MEDICINE, 19th edition, Volume-2, Part-16,
Section-1, 405, page no 2283-2285
3.Leung, AM; Braverman, LE; Pearce, EN (Nov 13, 2012). “History of U.S. iodine
fortificationandsupplementation”. Nutrients. 4 (11):17406. doi:10.3390/nu41 11740.
PMC 3509517 PMID 23201844. Archived from the original on 201401-02.
4.McAninch EA, Bianco AC (January 2016). “The History and Future of Treatment
of
Hypothyroidism”.Annals of Internal Medicine. 164 (1):506.doi:10.7326/M1517 PMC
4980994 PMID 26747302.
5.Murray, GR (Oct 10, 1891). “Note on the Treatment of Myxoedema by
Hypodermic Injections of an Extract of the Thyroid Gland of a Sheep”. British
Medical Journal. 2(1606):7967. doi:10.1136/bmj.2.1606.796. PMC 2273741.
PMID 2 0753415;
6. Fox, EL (Oct 29, 1892). “A Case of Myxoedema Treated by Taking Extract of
ThyroidbytheMouth”. BritishMedicalJournal. 2 (1661):941.
doi:10.1136/bmj.2.1661.941. PMC 2421284. PMID 20753901
7.McAninch EA, Bianco AC (January 2016). “The History and Future of Treatment
of Hypothyroidism”.AnnalsofInternalMedicine. 164
(1):506.doi:10.7326/M1517 PMC 4980994 PMID 26747302.
8. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer
CA, et al. Serum TSH, T (4), and thyroid antibodies in the United States population
(1988 to 1994):
National Health and Nutrition Examination Survey (NHANES III) J Clin Endocrinol
Metab. 2002;87:489–99; Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA,
Verbeek AL, Kiemency LA, et al. Thyroid function and prevalence of anti-
thyroperoxidase antibodies in a population with borderline sufficient iodine intake:
Influences of age and sex. Clin Chem. 2006; 52:104–11; Bemben DA, Hamm RM,
Morgan L, Winn P, Davis A, Barton E. Thyroid disease in the elderly. Part 2.
Predictability of subclinical hypothyroidism. J Fam Pract. 1994; 38:583–8.
9.Geneva: WHO; 2004. Iodine status worldwide, WHO global database on iodine
deficiency, Department of nutrition for health and development; Andersson M,
Takkouche B, Egli I, Allen HE, Benoist B. Current global iodine status and progress
over the last decade towards the elimination of iodine deficiency. Bull World Health
Organ. 2005; 83:518–25; Sunderesan S. Progress achieved in universal salt iodization
programme in India. In: Prakash R, Sunderesan S, Kapil U, editors. Proceedings of
symposium on elimination of IDD through universal access to iodized salt. New
Delhi: Shivnash Computers and Publications; 1998. pp. 28–42; Unnikrishnan AG,
Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J
Endocrinol Metab. 2011; 15:S78–81.
10.http://www.iisc.ernet.in/currsci/oct252000/n%20kochupillai.PDF;http://www.ncbi.nlm.nih
.gov/pubmed/8585400;http://www.ncbi.nlm.nih.gov/pubmed/10435859